{"id":25408,"date":"2020-11-08T08:59:20","date_gmt":"2020-11-08T08:59:20","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=25408"},"modified":"2020-11-08T08:59:20","modified_gmt":"2020-11-08T08:59:20","slug":"dolutegravir-tivicay%e2%96%bc-triumeq%e2%96%bc-juluca%e2%96%bc-updated-advice-on-increased-risk-of-neural-tube-defects","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2020\/11\/08\/dolutegravir-tivicay%e2%96%bc-triumeq%e2%96%bc-juluca%e2%96%bc-updated-advice-on-increased-risk-of-neural-tube-defects\/","title":{"rendered":"Dolutegravir (Tivicay\u25bc, Triumeq\u25bc, Juluca\u25bc): updated advice on increased risk of neural tube defects"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-24578\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/08\/arvs.jpg\" alt=\"\" width=\"250\" height=\"166\" \/><\/p>\n<p>Updated safety recommendations have been issued as part of the European review evaluating cases of neural tube defects in babies\u00a0<a href=\"https:\/\/www.gov.uk\/drug-safety-update\/dolutegravir-tivicay-triumeq-juluca-updated-advice-on-increased-risk-of-neural-tube-defects?UNLID=911058722202011885034\"> Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>Updated safety recommendations have been issued as part of the European review evaluating cases of neural tube defects in babies\u00a0 Read More<\/p>\n","protected":false},"author":1,"featured_media":24578,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-25408","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/08\/arvs.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/25408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=25408"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/25408\/revisions"}],"predecessor-version":[{"id":25409,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/25408\/revisions\/25409"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/24578"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=25408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=25408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=25408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}